Personalised cancer medicine and research: Today’s best practice

A proof-of-concept study of ODM-201 in patients with progressive castration-resistant prostate cancer

Prostate cancer screening and treatment

BRCA carrier status as a prognostic factor for prostate cancer

Retrospective study of optimal treatment for intermediate-risk testes cancer

Intermittent hormonal therapy versus continuous therapy for advanced prostate cancer

Intermittent hormonal therapy less effective than continuous therapy when treating advanced prostate cancer

Early results from new PD-1 targeted immune therapy

New study asks patients preference on kidney cancer treatment

Evidence for TORC1 activation marker as a predictive factor for everolimus efficacy in metastatic breast cancer

Long term survival with testicular cancer

Supportive care for men with prostate cancer